Last updated: April 3, 2025
Sponsor: Abbott Medical Devices
Overall Status: Active - Recruiting
Phase
N/A
Condition
Cardiac Disease
Arrhythmia
Dysrhythmia
Treatment
Aveir DR Leadless Pacemaker System
Dual Chamber Transvenous Pacemaker
Clinical Study ID
NCT05932602
ABT-CIP-1020548
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Medicare beneficiaries implanted with an Aveir DR leadless pacemaker on or after thestudy start date (i.e., the date of Aveir DR market approval) will be included inthe study.
OR
Medicare beneficiaries implanted with a full system (e.g. lead and generator) dual-chamber transvenous pacemaker on or after the study start date
Exclusion
Exclusion Criteria:
None
Study Design
Total Participants: 2812
Treatment Group(s): 2
Primary Treatment: Aveir DR Leadless Pacemaker System
Phase:
Study Start date:
October 31, 2023
Estimated Completion Date:
May 31, 2030
Study Description
Connect with a study center
Abbott
Sylmar, California 91342
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.